Fox Run Management L.L.C. Has $213,000 Stock Position in Cabot Corporation $CBT

Fox Run Management L.L.C. cut its position in Cabot Corporation (NYSE:CBTFree Report) by 56.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,558 shares of the specialty chemicals company’s stock after selling 3,346 shares during the quarter. Fox Run Management L.L.C.’s holdings in Cabot were worth $213,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Copeland Capital Management LLC boosted its position in shares of Cabot by 5.8% during the 1st quarter. Copeland Capital Management LLC now owns 805,504 shares of the specialty chemicals company’s stock valued at $66,970,000 after purchasing an additional 44,132 shares in the last quarter. Northern Trust Corp increased its stake in shares of Cabot by 12.4% in the 4th quarter. Northern Trust Corp now owns 794,477 shares of the specialty chemicals company’s stock valued at $72,544,000 after acquiring an additional 87,881 shares in the last quarter. LSV Asset Management lifted its position in shares of Cabot by 318.0% during the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock valued at $47,476,000 after acquiring an additional 434,434 shares during the period. Millennium Management LLC boosted its stake in Cabot by 67.7% during the fourth quarter. Millennium Management LLC now owns 349,369 shares of the specialty chemicals company’s stock worth $31,901,000 after acquiring an additional 141,050 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in Cabot by 1.5% in the fourth quarter. Ameriprise Financial Inc. now owns 214,135 shares of the specialty chemicals company’s stock worth $19,553,000 after purchasing an additional 3,240 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Insiders Place Their Bets

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the company’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the sale, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at approximately $28,661,147.04. This represents a 24.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 3.03% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CBT. UBS Group set a $82.00 price objective on shares of Cabot and gave the company a “neutral” rating in a report on Tuesday, August 5th. Wall Street Zen lowered Cabot from a “buy” rating to a “hold” rating in a research report on Wednesday, May 7th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $92.33.

Get Our Latest Analysis on CBT

Cabot Stock Down 0.2%

CBT stock opened at $79.2560 on Thursday. The firm has a market capitalization of $4.22 billion, a PE ratio of 10.36 and a beta of 0.87. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Cabot Corporation has a twelve month low of $70.40 and a twelve month high of $117.46. The stock’s 50 day moving average is $76.46 and its 200-day moving average is $79.00.

Cabot (NYSE:CBTGet Free Report) last released its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The business had revenue of $923.00 million during the quarter, compared to analyst estimates of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Sell-side analysts expect that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 11th. Investors of record on Friday, August 29th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.3%. Cabot’s payout ratio is currently 23.53%.

Cabot Company Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.